Fosun Pharma Sells 4.5% Stake in Gland Pharma for Rs 2,121 Crore
Chinese pharmaceutical company Fosun Pharma sold a 4.5% stake in Hyderabad-based Gland Pharma for Rs 2,121 crore through block deals on the BSE, reducing its holding to 47.22% from 51.77%. The shares were acquired by domestic mutual funds, insurance firms, and foreign investors, with Kotak Mahindra Mutual Fund as the largest buyer. Gland Pharma's shares rose nearly 1% post-sale. The company reported a 47% increase in consolidated net profit to Rs 317 crore and a 19.5% rise in revenue to Rs 1,800 crore in the April-June quarter.
First-hand measurement across 7 sources
We measured how 7 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (55/100). Lens Score 42/100.
Outlets measured: moneycontrol, news18, moneycontrol, economictimes, economictimes, economictimes, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–70/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 3 Sept, 03:53 pm. Other outlets followed.